LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4598 | 4513 | 1.0188 | 1.0258 |
MDA-MB-231 | PIK-93 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4444 | 4513 | 0.9847 | 0.9790 |
MDA-MB-231 | KIN001-043 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3783 | 4513 | 0.8382 | 0.7772 |
MDA-MB-231 | Alpelisib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4387 | 4513 | 0.9720 | 0.9615 |
MDA-MB-231 | Luminespib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 847 | 4513 | 0.1877 | -0.1187 |
MDA-MB-231 | A443654 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3529 | 4513 | 0.7819 | 0.6996 |
MDA-MB-231 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4518 | 4513 | 1.0011 | 1.0015 |
MDA-MB-231 | XMD11-85h | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3707 | 4513 | 0.8213 | 0.7539 |
MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3983 | 4513 | 0.8825 | 0.8382 |
MDA-MB-231 | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3774 | 4513 | 0.8363 | 0.7745 |
MDA-MB-231 | WZ-4-145 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3498 | 4513 | 0.7751 | 0.6903 |
MDA-MB-231 | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1465 | 4513 | 0.3247 | 0.0700 |
MDA-MB-231 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4067 | 4513 | 0.9011 | 0.8637 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4633 | 4513 | 1.0265 | 1.0365 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4297 | 4513 | 0.9522 | 0.9341 |
MDA-MB-231 | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4465 | 4513 | 0.9893 | 0.9853 |
MDA-MB-231 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1235 | 5069 | 4513 | 1.1232 | 1.1696 |
MDA-MB-231 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3304 | 4513 | 0.7321 | 0.6311 |
MDA-MB-231 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 534 | 4513 | 0.1183 | -0.2142 |
MDA-MB-231 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3927 | 4513 | 0.8700 | 0.8210 |
MDA-MB-231 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4774 | 4513 | 1.0577 | 1.0794 |
MDA-MB-231 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4695 | 4513 | 1.0403 | 1.0555 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4502 | 4513 | 0.9974 | 0.9965 |
MDA-MB-231 | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4092 | 4513 | 0.9067 | 0.8715 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2691 | 4513 | 0.5962 | 0.4439 |